Online inquiry

IVTScrip™ mRNA-Human ADGRG5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10743MR)

This product GTTS-WK10743MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRG5 protein. This product can be used in CD4+ cytotoxic T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001304376.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 221188
UniProt ID Q8IZF4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRG5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10743MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK24204MR IVTScrip™ mRNA-Human ASCC3, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ASCC3
GTTS-WK22269MR IVTScrip™ mRNA-Human ARFGAP1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARFGAP1
GTTS-WK13785MR IVTScrip™ mRNA-Human AFG3L2, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AFG3L2
GTTS-WK20019MR IVTScrip™ mRNA-Human ANKRD36, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD36
GTTS-WK17909MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK11589MR IVTScrip™ mRNA-Human ADAM12, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAM12
GTTS-WK15026MR IVTScrip™ mRNA-Human AHSA1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AHSA1
GTTS-WK28314MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGEF26
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →